Doppel protein (Dpl) is a paralog of the cellular form of the prion protein (PrPC), together sharing common structural and biochemical properties. Unlike PrPC, which is abundantly expressed throughout the central nervous system (CNS), Dpl protein expression is not detectable in the CNS. Interestingly, its ectopic expression in the brain elicits neurodegeneration in transgenic mice. Here, by combining native isoelectric focusing plus non-denaturing polyacrylamide gel electrophoresis and mass spectrometry analysis, we identified two Dpl binding partners: rat alpha-1-inhibitor-3 (α1I3) and, by sequence homology, alpha-2-macroglobulin (α2M), two known plasma metalloproteinase inhibitors. Biochemical investigations excluded the direct interaction of PrPC with either α1I3 or α2M. Nevertheless, enzyme-linked immunosorbent assays and surface plasmon resonance experiments revealed a high affinity binding occurring between PrPC and Dpl. In light of these findings, we suggest a mechanism for Dpl-induced neurodegeneration in mice expressing Dpl ectopically in the brain, linked to a withdrawal of natural inhibitors of metalloproteinase such as α2M. Interestingly, α2M has been proven to be a susceptibility factor in Alzheimer's disease, and as our findings imply, it may also play a relevant role in other neurodegenerative disorders, including prion diseases.
References
[1]
Prusiner SB (1998) Prions (Les Prix Nobel Lecture). In: Fr？ngsmyr T, editor. Les Prix Nobel. Stockholm, Sweden: Almqvist & Wiksell International. pp. 268–323.
[2]
Prusiner SB (2001) Shattuck Lecture — Neurodegenerative diseases and prions. N Engl J Med 344: 1516–1526.
[3]
Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, et al. (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 292: 797–817.
[4]
Silverman GL, Qin K, Moore RC, Yang Y, Mastrangelo P, et al. (2000) Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss. J Biol Chem 275: 26834–26841.
[5]
Mo H, Moore RC, Cohen FE, Westaway D, Prusiner SB, et al. (2001) Two different neurodegenerative diseases caused by proteins with similar structures. Proc Natl Acad Sci U S A 98: 2352–2357.
[6]
Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, et al. (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380: 528–531.
[7]
Moore RC, Hope J, McBride PA, McConnell I, Selfridge J, et al. (1998) Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet 18: 118–125.
[8]
Moore RC, Mastrangelo P, Bouzamondo E, Heinrich C, Legname G, et al. (2001) Doppel-induced cerebellar degeneration in transgenic mice. Proc Natl Acad Sci U S A 98: 15288–15293.
[9]
Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, et al. (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93: 203–214.
[10]
Behrens A (2003) Physiological and pathological functions of the prion protein homologue Dpl. Br Med Bull 66: 35–42.
Chacon MA, Barria MI, Lorca R, Huidobro-Toro JP, Inestrosa NC (2003) A human prion protein peptide (PrP(59–91)) protects against copper neurotoxicity. Mol Psychiatry 8: 853–862.835
[13]
Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, et al. (2005) Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 25: 11330–11339.
[14]
Legname G, Nelken P, Guan Z, Kanyo ZF, DeArmond SJ, et al. (2002) Prion and doppel proteins bind to granule cells of the cerebellum. Proc Natl Acad Sci U S A 99: 16285–16290.
[15]
Caughey B, Baron GS (2006) Prions and their partners in crime. Nature 443: 803–810.
[16]
Chu C, Pizzo S (1994) alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. Lab Invest 71: 792–812.
[17]
Saravis C, O'Brien M, Zamcheck N (1979) Direct tissue isoelectric focusing in agarose. J Immunol Methods 29: 97–100.
[18]
Willoughby E, Lambert A (1983) A sensitive silver stain for proteins in agarose gels. Anal Biochem 130: 353–358.
[19]
Walker R, Keir G, Johnson M, Thompson E (1983) A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol 4: 141–148.
[20]
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850–858.
[21]
Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551–3567.
[22]
Altschul SF, Madden TL, Sch？ffer AA, Zhang Z, Miller W, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389–3402.
[23]
Thompson J, Higgins D, Gibson T (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673–4680.
[24]
Page R (1996) TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 12: 357–358.
[25]
Imber M, Pizzo S (1981) Clearance and binding of two electrophoretic “fast” forms of human alpha 2-macroglobulin. J Biol Chem 256: 8134–8139.
[26]
Enghild J, Th？gersen I, Roche P, Pizzo S (1989) A conserved region in alpha-macroglobulins participates in binding to the mammalian alpha-macroglobulin receptor. Biochemistry 28: 1406–1412.
[27]
Harlow E, Lane D (1988) Antibodies: A Laboratory Manual. 726. Cold Spring Harbor: Cold Spring Harbor Laboratory.
[28]
Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, et al. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412: 739–743.
[29]
Serban D, Taraboulos A, DeArmond SJ, Prusiner SB (1990) Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40: 110–117.
[30]
Ryou C, Prusiner SB, Legname G (2003) Cooperative binding of dominant-negative prion protein to kringle domains. J Mol Biol 329: 323–333.
[31]
Geiger T, Lamri Y, Tran-Thi T, Gauthier F, Feldmann G, et al. (1987) Biosynthesis and regulation of rat alpha 1-inhibitor3, a negative acute-phase reactant of the macroglobulin family. Biochem J 245: 493–500.
[32]
Sottrup-Jensen L, Sand O, Kristensen L, Fey G (1989) The alpha-macroglobulin bait region. Sequence diversity and localization of cleavage sites for proteinases in five mammalian alpha-macroglobulins. J Biol Chem 264: 15781–15789.
[33]
Li A, Sakaguchi S, Shigematsu K, Atarashi R, Roy BC, et al. (2000) Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP-deficient mice ataxic due to Purkinje cell degeneration. Am J Pathol 157: 1447–1452.
[34]
Atarashi R, Nishida N, Shigematsu K, Goto S, Kondo T, et al. (2003) Deletion of N-terminal residues 23–88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration. J Biol Chem 278: 28944–28949.
[35]
Behrens A, Genoud N, Naumann H, Rulicke T, Janett F, et al. (2002) Absence of the prion protein homologue Doppel causes male sterility. EMBO J 21: 3652–3658.
[36]
Paisley D, Banks S, Selfridge J, McLennan NF, Ritchie AM, et al. (2004) Male infertility and DNA damage in Doppel knockout and prion protein/Doppel double-knockout mice. Am J Pathol 164: 2279–2288.
[37]
Zhu L, Cheng C, Phillips D, Bardin C (1994) The immunohistochemical localization of alpha 2-macroglobulin in rat testes is consistent with its role in germ cell movement and spermiation. J Androl 15: 575–582.
[38]
Wong C, Mruk D, Siu M, Cheng C (2005) Blood-testis barrier dynamics are regulated by {alpha}2-macroglobulin via the c-Jun N-terminal protein kinase pathway. Endocrinology 146: 1893–1908.
[39]
Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, et al. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19: 357–360.
[40]
Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, et al. (1998) Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet 7: 1953–1956.
[41]
Dodel RC, Du Y, Bales KR, Gao F, Eastwood B, et al. (2000) Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology 54: 438–442.
[42]
Saunders AJ, Tanzi RE (2003) Welcome to the complex disease world Alpha2-macroglobulin and Alzheimer's disease. Experimental Neurology 184: 50–53.
[43]
Strauss S, Bauer J, Ganter U, Jonas U, Berger M, et al. (1992) Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66: 223–230.
[44]
Hyman BT, Strickland DK, Rebeck GW (1994) Alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Relationship to apolipoprotein E and role in Alzheimer disease senile plaques. Ann N Y Acad Sci 737: 88–95.
[45]
Rebeck GW, Harr SD, Strickland DK, Hyman BT (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 37: 211–217.
[46]
Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, et al. (1995) LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82: 331–340.
[47]
Narita M, Holtzman DM, Schwartz AL, Bu G (1997) Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem 69: 1904–1911.
[48]
Hyman BT, Strickland D, Rebeck GW (2000) Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease. Arch Neurol 57: 646–650.
[49]
Taylor DR, Hooper NM (2007) The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J 402: 17–23.
[50]
Parkyn CJ, Vermeulen EG, Mootoosamy RC, Sunyach C, Jacobsen C, et al. (2008) LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J Cell Sci 121: 773–783.
[51]
Adler V, Davidowitz E, Tamburi P, Rojas P, Grossman A (2007) Alpha2-macroglobulin is a potential facilitator of prion protein transformation. Amyloid 14: 1–10.
[52]
Watts JC, Westaway D (2007) The prion protein family: diversity, rivalry, and dysfunction. Biochim Biophys Acta 1772: 654–672.
[53]
Büeler H, Fisher M, Lang Y, Bluethmann H, Lipp H-P, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577–582.
[54]
Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, et al. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8: 121–127.
[55]
Rossi D, Cozzio A, Flechsig E, Klein MA, Rulicke T, et al. (2001) Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J 20: 694–702.
